DIMENSIONAL FUND ADVISORS LP - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 94 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$45,805,000
+65.8%
7,596,123
-1.0%
0.02%
+54.5%
Q3 2019$27,628,000
+34.1%
7,674,201
-0.1%
0.01%
+37.5%
Q2 2019$20,597,000
-7.9%
7,685,598
+1.8%
0.01%
-11.1%
Q1 2019$22,358,000
+88.9%
7,553,328
+1.5%
0.01%
+80.0%
Q4 2018$11,833,000
-55.2%
7,442,477
+3.6%
0.01%
-50.0%
Q3 2018$26,433,000
+35.5%
7,182,715
+4.2%
0.01%
+25.0%
Q2 2018$19,505,000
-13.0%
6,892,184
+14.1%
0.01%
-11.1%
Q1 2018$22,418,000
+64.6%
6,042,463
+27.8%
0.01%
+50.0%
Q4 2017$13,616,000
-7.4%
4,727,583
+44.3%
0.01%0.0%
Q3 2017$14,710,000
+71.5%
3,276,076
+75.3%
0.01%
+50.0%
Q2 2017$8,579,000
+232.4%
1,868,968
+204.9%
0.00%
+300.0%
Q1 2017$2,581,000
+54.0%
613,006
+51.1%
0.00%0.0%
Q4 2016$1,676,000
+65.3%
405,802
+224.2%
0.00%0.0%
Q3 2016$1,014,000
+3.9%
125,1820.0%0.00%0.0%
Q2 2016$976,000
-2.7%
125,182
-3.7%
0.00%0.0%
Q1 2016$1,003,000
+328.6%
129,982
+447.1%
0.00%
Q1 2015$234,000
-92.8%
23,759
-91.0%
0.00%
-100.0%
Q4 2014$3,246,000
+22.7%
265,0000.0%0.00%0.0%
Q3 2014$2,645,000
+31.9%
265,0000.0%0.00%
+100.0%
Q2 2014$2,006,000
+313.6%
265,000
+79.9%
0.00%
Q1 2014$485,000
-32.5%
147,342
-31.9%
0.00%
-100.0%
Q4 2013$718,000
+2216.1%
216,308
+2020.7%
0.00%
Q3 2013$31,000
+675.0%
10,200
+1940.0%
0.00%
Q2 2013$4,0005000.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2013
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders